The current analyst and expert consensus on Alexion Pharmaceuticals is Buy with 7 hold recommendations. The current projected target price consensus is 160.5 with 16 analysts opinions. One of the most common ways Alexion Pharmaceuticals analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Alexion Pharmaceuticals vendors, executives, and/or customers. Alexion Pharmaceuticals recommendation module provides expert sentiment on the projected Alexion Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 24.314. Check also Macroaxis Advice on Alexion Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.